| Cleveland Clinic Journal of Medicine, accessed April 22, 2025, How to Increase GLP-1 Naturally With Supplements and Foods - GoodRx, accessed April 22, 2025, GLP-1 Drugs and Muscle Loss: What Patients Need to Know - Highbar Physical Therapy, accessed April 22, 2025, Why Protein Is Intake Is Important With GLP-1 Medication - Evercare Wellness, accessed April 22, 2025, How to preserve muscle on weight-loss drugs like Wegovy, accessed April 22, 2025, What to Eat on a GLP-1 Diet, According to a Dietitian | Anytime Fitness, accessed April 22, 2025, How to deal with side effects from weight loss medications | SIU School of Medicine, accessed April 22, 2025, How GLP-1 Medications Affect Brain Chemistry and Cravings - Genesis Lifestyle Medicine, accessed April 22, 2025, Embracing Satiety: How GLP-1 Agonists Help Reconnect You to Your Fullness Cues, accessed April 22, 2025, GLP-1 Medications and Eating Disorders: What You Should Know - The Emily Program, accessed April 22, 2025, Surprises and Concerns About GLP-1 Medications - The University of Kansas Health System, accessed April 22, 2025, 7 Easy Ways to Manage Extreme Hunger After Stopping Ozempic, Wegovy - Healthline, accessed April 22, 2025, What Is Food Noise
I worked with a practitioner: We optimized my hormones with bioidentical HRT (alongside all of the foundational food & lifestyle things I had already integrated CANT skip this part folks!) AND I decided to try a very low dose of semaglutide (a GLP-1 agonist) When I say low dose, I mean low : I started at 50 mcg I am now at 100 mcg For context: pharmaceutical semaglutide (like Ozempic/Wegovy) typically starts around 0.25 mg0.5 mg (250-500 mcg) and goes up to 2.4 mg
With the gradual progression of atherosclerotic plaques, atherosclerosis will induce angina pectoris, or cerebral ischemia, leading to severe clinical manifestations such as heart failure, myocardial infarction (MI), cerebral infarction and lower limb ischemia and amputation [2]
(2016) 95:e2891
Identified as the first incretin in the 1970s (see section I), GIP has historically been thought to have little therapeutic potential
